Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2026-02-26 @ 11:00 AM
Study NCT ID:
NCT05713851
Status:
RECRUITING
Last Update Posted:
2024-03-05
First Post:
2023-01-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dapaglifozin to Avoid Acute Kindey Injury (AKI) to Chronic Kidney Disease (CKD) Transition: DAKI-CKD Study
Sponsor:
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-01-26
First Submit QC Date:
None
Study First Post Date:
2023-02-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-04
Last Update Post Date:
2024-03-05
Last Update Post Date Type:
ACTUAL